These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15320885)

  • 61. Ultrastructural features of macrophages of armadillos infected with actively multiplying Mycobacterium leprae.
    Fukunishi Y; Meyers WM; Walsh GP; Johnson FB; Binford CH; Okada S; Nishiura M
    Int J Lepr Other Mycobact Dis; 1984 Jun; 52(2):198-202. PubMed ID: 6373628
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vivo effect of delipidified cell component of Mycobacterium leprae in relation to infection with leprosy bacteria in mice.
    Damle A; Mahadevan PR
    Indian J Lepr; 1993; 65(3):271-82. PubMed ID: 8283062
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Autophagy links antimicrobial activity with antigen presentation in Langerhans cells.
    Dang AT; Teles RM; Liu PT; Choi A; Legaspi A; Sarno EN; Ochoa MT; Parvatiyar K; Cheng G; Gilliet M; Bloom BR; Modlin RL
    JCI Insight; 2019 Apr; 4(8):. PubMed ID: 30996142
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Concentration-dependent effects of mycobacteria on the stimulation of murine T-cell clones.
    Kingston AE; Colston MJ
    Acta Leprol; 1984; 2(2-4):369-77. PubMed ID: 6398595
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Macrophage membrane alterations in leprosy as determined by change in sialic acid level.
    Agarwal S; Vemuri N; Mahadevan PR
    J Clin Lab Immunol; 1986 Mar; 19(3):119-22. PubMed ID: 3519974
    [TBL] [Abstract][Full Text] [Related]  

  • 66. S100A12 Is Part of the Antimicrobial Network against Mycobacterium leprae in Human Macrophages.
    Realegeno S; Kelly-Scumpia KM; Dang AT; Lu J; Teles R; Liu PT; Schenk M; Lee EY; Schmidt NW; Wong GC; Sarno EN; Rea TH; Ochoa MT; Pellegrini M; Modlin RL
    PLoS Pathog; 2016 Jun; 12(6):e1005705. PubMed ID: 27355424
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intrinsic activation of the vitamin D antimicrobial pathway by M. leprae infection is inhibited by type I IFN.
    Zavala K; Gottlieb CA; Teles RM; Adams JS; Hewison M; Modlin RL; Liu PT
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006815. PubMed ID: 30300363
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Respiratory burst metabolic status of macrophages in experimental leprosy.
    Kohli M; Vaishnavi C; Jaswal S; Kaur S; Ganguly NK
    J Hyg Epidemiol Microbiol Immunol; 1992; 36(2):201-6. PubMed ID: 1512456
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Induction of unresponsiveness to gamma interferon in macrophages infected with Mycobacterium leprae.
    Sibley LD; Krahenbuhl JL
    Infect Immun; 1988 Aug; 56(8):1912-9. PubMed ID: 2840398
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Thalidomide does not modify the ability of cells in leprosy patients to incorporate [3H]-thymidine when incubated with M. leprae antigens.
    Tadesse A; Taye E; Sandoval F; Shannon EJ
    Lepr Rev; 2003 Sep; 74(3):206-14. PubMed ID: 14577465
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cholesterol dynamics in macrophages implication for the bacteriology and pathology of leprosy.
    Kato L
    Acta Leprol; 1979; (75):35-47. PubMed ID: 121019
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Mechanism of immunosuppression in leprosy--macrophage membrane alterations.
    Salgame PR; Birdi TJ; Lad SJ; Mahadevan PR; Antia NH
    J Clin Lab Immunol; 1984 Jul; 14(3):145-9. PubMed ID: 6384522
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The cell fate regulator NUPR1 is induced by Mycobacterium leprae via type I interferon in human leprosy.
    R Andrade P; Mehta M; Lu J; M B Teles R; Montoya D; O Scumpia P; Nunes Sarno E; Ochoa MT; Ma F; Pellegrini M; Modlin RL
    PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007589. PubMed ID: 31344041
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ability of M. leprae, Mycobacterium w, and ICRC bacillus to produce macrophage activating factors from lymphocytes of leprosy patients.
    Prasad HK; Singh AK; Talwar GP
    Lepr India; 1978 Oct; 50(4):539-49. PubMed ID: 374871
    [No Abstract]   [Full Text] [Related]  

  • 75. Immunoprophylaxis against Mycobacterium leprae infection with subunit vaccines.
    Britton WJ; Martin E; Kamath AT; Neupane KD; Roche PW
    Lepr Rev; 2000 Dec; 71 Suppl():S176-81. PubMed ID: 11201878
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The immunology of leprosy; unravelling an enigma.
    Choudhuri K
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):430-47. PubMed ID: 7594927
    [No Abstract]   [Full Text] [Related]  

  • 77. An electron microscopic study on macrophages and lymphocytes in lepromatous and borderline leprosy.
    Burchard GD; Bierther M
    Int J Lepr Other Mycobact Dis; 1985 Mar; 53(1):64-9. PubMed ID: 3889192
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The behavior of leprous lymphocytes and macrophages in the macrophage migration-inhibition test.
    Han SH; Weiser RS; Wang JJ; Tsai LC; Lin PP
    Int J Lepr Other Mycobact Dis; 1974; 42(2):186-92. PubMed ID: 4609929
    [No Abstract]   [Full Text] [Related]  

  • 79. Mycobacterium leprae-induced Insulin-like Growth Factor I attenuates antimicrobial mechanisms, promoting bacterial survival in macrophages.
    Batista-Silva LR; Rodrigues LS; Vivarini Ade C; Costa Fda M; Mattos KA; Costa MR; Rosa PS; Toledo-Pinto TG; Dias AA; Moura DF; Sarno EN; Lopes UG; Pessolani MC
    Sci Rep; 2016 Jun; 6():27632. PubMed ID: 27282338
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ultrastructural features of the multiplication of human and murine leprosy bacilli in macrophages of nude mice.
    Fukunishi Y; Okada S; Nishiura M; Kohsaka K
    Int J Lepr Other Mycobact Dis; 1982 Mar; 50(1):68-75. PubMed ID: 7042613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.